Gilead Sciences chairman and CEO Daniel O’Day joins 'Squawk Box' to discuss the FDA approval of the company's HIV prevention ...

Daraxonrasib has received breakthrough therapy designation from the FDA for KRAS G12+, previously treated, metastatic ...

Senator Katie Britt, R-Alabama, took to social media this weekend to criticize the use of artificial food dyes. In a Saturday post on X, Britt shared an April story from WHNT News 19 about a ...

But one of the standout moments during the hearing occurred when Kennedy suggested that a sitting member of Congress only ...

Health and Human Services Secretary Robert F. Kennedy Jr. testified in front of the House Committee on Energy and Commerce ...

The elimination of 3,500 full-time employees at the FDA risks undermining the very innovation and domestic capacity the ...

The injectable HIV prevention treatment Yetzugo, made by Gilead Sciences, has received FDA approval, offering a twice-yearly ...

Clinical trials showed 99.9% of participants who received the drug, called Yeztugo​ from company Gilead Sciences, remained ...

A House Energy & Commerce’s Health subcommittee came to a brief halt on Tuesday as the Republican chair asked Health Secretary Robert F. Kennedy Jr. to retract his accusations that a ...

The FDA has approved darolutamide without chemotherapy for treatment of metastatic hormone-sensitive prostate cancer.The FDA based its approval off results from the randomized phase 3 ARANOTE ...

The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported ...